The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Hypoxia-Modified Cancer Cell Metabolism
Open accessAbstract
While oxygen is critical to the continued existence of complex organisms, extreme levels of oxygen within a system, known as hypoxia (low levels of oxygen) and hyperoxia (excessive levels of oxygen), potentially promote stress within a defined biological environment. The consequences of tissue hypoxia, a result of a defective oxygen supply, vary in response to the gravity, extent and environment of the malfunction. Persistent pathological hypoxia is incompatible with normal biological functions, and as a result, multicellular organisms have been compelled to develop both organism-wide and cellular-level hypoxia solutions. Both direct, including oxidative phosphorylation down-regulation and inhibition of fatty-acid desaturation, and indirect processes, including altered hypoxia-sensitive transcription factor expression, facilitate the metabolic modifications that occur in response to hypoxia. Due to the dysfunctional vasculature associated with large areas of some cancers, sections of these tumors continue to develop in hypoxic environments. Crucial to drug development, a robust understanding of the significance of these metabolism changes will facilitate our understanding of cancer cell survival. This review defines our current knowledge base of several of the hypoxia-instigated modifications in cancer cell metabolism and exemplifies the correlation between metabolic change and its support of the hypoxic-adapted malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“Rather than only being determined by cancer cells, cancer progression is the product of the entire tumor microenvironment, including cancer cells, extracellular matrix (ECM) and stroma (Hanahan and Coussens, 2012).”
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2007) · W.W. Norton eBooks · doi:10.1201/9780203833445 · Cited by 4,589
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
(1989) · PubMed · Cited by 3,343
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Epigenetics and the environment: emerging patterns and implications
Feil, R., & Fraga, M. F. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3142 · Cited by 1,929
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871 · cited 3×
“This hydroxylation is due to factor inhibiting HIF (FIH), which restricts co-activation with p300, thereby inhibiting HIF transcriptional activation (Masoud and Li, 2015).”
BackgroundHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035 · cited 1×
“, fumarate hydratase (FH), the subunits of succinate dehydrogenase (SDH), and isocitrate dehydrogenase (IDH1 and IDH2)] can give rise to a condition termed pseudo-hypoxia by formation of a reduced variety of 2-oxoglutarate, (R)-2-hydroxyglutarate, as an oncometabolite, involving activation of HIF-1, irrespective of a…”
BackgroundRadiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
The role of oxygen availability in embryonic development and stem cell function
Simon, M. C., & Keith, B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2354 · Cited by 967
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
ZHENG, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 963
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941
Covello, K. L., Kehler, J., Yu, H., Gordan, J. D., Arsham, A. M., Hu, C.-J., Labosky, P. A., Simon, M. C., & Keith, B. (2006) · Genes & Development · doi:10.1101/gad.1399906 · Cited by 821
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 782
Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response
Vaupel, P., & Harrison, L. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-4 · Cited by 761
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727
Kallio, P. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6573 · Cited by 666
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
Mansfield, K. D., Guzy, R. D., Pan, Y., Young, R. M., Cash, T. P., Schumacker, P. T., & Simon, M. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.003 · Cited by 606
Zimna, A., & Kurpisz, M. (2015) · BioMed Research International · doi:10.1155/2015/549412 · Cited by 604
Giannoni, E., Bianchini, F., Masieri, L., Serni, S., Torre, E., Calorini, L., & Chiarugi, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0785 · Cited by 596
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Treatment Resistance of Solid Tumors
Vaupel, P., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 558
On respiratory impairment in cancer cells
Weinhouse, S. (1956) · Science · doi:10.1126/science.124.3215.267 · Cited by 554
Mole, D. R., Blancher, C., Copley, R. R., Pollard, P. J., Gleadle, J. M., Ragoussis, J., & Ratcliffe, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901790200 · Cited by 552
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.004 · Cited by 523
Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates
Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610415200 · Cited by 521
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Cirri, P., & Chiarugi, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9340-x · Cited by 519
Glucose transporters in cancer – from tumor cells to the tumor microenvironment
Ancey, P., Contat, C., & Meylan, E. (2018) · The FEBS Journal · doi:10.1111/febs.14577 · Cited by 514
HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477
The facilitative glucose transporter GLUT3: 20 years of distinction
Simpson, I. A., Dwyer, D., Malide, D., Moley, K. H., Travis, A., & Vannucci, S. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90388.2008 · Cited by 473
Giannoni, E., Buricchi, F., Raugei, G., Ramponi, G., & Chiarugi, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6391-6403.2005 · Cited by 455
MicroRNAs: Novel regulators in the hallmarks of human cancer
Ruan, K., Fang, X., & Ouyang, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.031 · Cited by 447
Koukourakis, M. I., Giatromanolaki, A., Harris, A. L., & Sivridis, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3260 · Cited by 440
MicroRNA regulation of DNA repair gene expression in hypoxic stress
Crosby, M. E., Kulshreshtha, R., Ivan, M., & Glazer, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2516 · Cited by 437
Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Barron, C. C., Bilan, P. J., Tsakiridis, T., & Tsiani, E. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.007 · Cited by 435
Lum, J. J., Bui, T., Gruber, M., Gordan, J. D., DeBerardinis, R. J., Covello, K. L., Simon, M. C., & Thompson, C. B. (2007) · Genes & Development · doi:10.1101/gad.1529107 · Cited by 429
Role and regulation of prolyl hydroxylase domain proteins
Fong, G.-H., & Takeda, K. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.10 · Cited by 427
Chen, Z., Li, Y., Zhang, H., Huang, P., & Luthra, R. (2010) · Oncogene · doi:10.1038/onc.2010.193 · Cited by 426
Activation of the HIF pathway in cancer
Maxwell, P. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426
Puisségur, M.-P., Mazure, N. M., Bertero, T., Pradelli, L., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V, et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.119 · Cited by 423
Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML
Saito, Y., Uchida, N., Tanaka, S., Suzuki, N., Tomizawa-Murasawa, M., Sone, A., Najima, Y., Takagi, S., Aoki, Y., Wake, A., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1607 · Cited by 419
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Moeller, B. J., Richardson, R. A., & Dewhirst, M. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9056-0 · Cited by 415
Erler, J. T., Cawthorne, C. J., Williams, K. J., Koritzinsky, M., Wouters, B. G., Wilson, C., Miller, C., Demonacos, C., Stratford, I. J., & Dive, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2875-2889.2004 · Cited by 400
Jögi, A., Øra, I., Nilsson, H., Lindeheim, Å., Makino, Y., Poellinger, L., Axelson, H., & Påhlman, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102660199 · Cited by 399
Kunkel, M., Reichert, T. E., Benz, P., Lehr, H., Jeong, J., Wieand, S., Bartenstein, P., Wagner, W., & Whiteside, T. L. (2003) · Cancer · doi:10.1002/cncr.11159 · Cited by 390
Nutrient acquisition strategies of mammalian cells
Palm, W., & Thompson, C. B. (2017) · Nature · doi:10.1038/nature22379 · Cited by 388
Oxygen, a source of life and stress
Brahimi-Horn, M. C., & Pouysségur, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.018 · Cited by 383
Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
Vaupel, P. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-21 · Cited by 383
Biological consequences of tumor hypoxia
HOCKEL, M. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90211-8 · Cited by 382
Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes
Harrison, L. B., Chadha, M., Hill, R. J., Hu, K., & Shasha, D. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-492 · Cited by 376
Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint
Owusu-Ansah, E., Yavari, A., Mandal, S., & Banerjee, U. (2008) · Nature Genetics · doi:10.1038/ng.2007.50 · Cited by 373
Cancer associated fibroblasts: An essential role in the tumor microenvironment
Tao, L., Huang, G., Song, H., Chen, Y., & Chen, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6497 · Cited by 351
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Cao, J., Schulte, J., Knight, A., Leslie, N. R., Zagozdzon, A., Bronson, R., Manevich, Y., Beeson, C., & Neumann, C. A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.101 · Cited by 344
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
Giannakakis, A., Sandaltzopoulos, R., Greshock, J., Liang, S., Huang, J., Hasegawa, K., Li, C., O'Brien-Jenkins, A., Katsaros, D., Weber, B. L., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.2.5297 · Cited by 344
Favaro, E., Ramachandran, A., McCormick, R., Gee, H., Blancher, C., Crosby, M., Devlin, C., Blick, C., Buffa, F., Li, J.-L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010345 · Cited by 324
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315
Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction
Das, B., Tsuchida, R., Malkin, D., Koren, G., Baruchel, S., & Yeger, H. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0724 · Cited by 309
Peng, X.-H., Karna, P., Cao, Z., Jiang, B.-H., Zhou, M., & Yang, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603414200 · Cited by 300
MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia
Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S. F., Cheong, A., Scholz, C. C., Simpson, D. A., Leonard, M. O., Tambuwala, M. M., Cummins, E. P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01276-10 · Cited by 289
Welsh, S. J., Williams, R. R., Kirkpatrick, L., Paine-Murrieta, G. D., & Powis, G. (2004) · PubMed · Cited by 280
An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
Fasanaro, P., Greco, S., Lorenzi, M., Pescatori, M., Brioschi, M., Kulshreshtha, R., Banfi, C., Stubbs, A., Calin, G. A., Ivan, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052779 · Cited by 268
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
Wong, C. C., Qian, Y., & Yu, J. (2017) · Oncogene · doi:10.1038/onc.2016.485 · Cited by 262
Epigenetic mechanisms and cancer: An interface between the environment and the genome
Herceg, Z., & Vaissière, T. (2011) · Epigenetics · doi:10.4161/epi.6.7.16262 · Cited by 256
Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
Guo, S., Kim, W. J., Lok, J., Lee, S.-R., Besancon, E., Luo, B.-H., Stins, M. F., Wang, X., Dedhar, S., & Lo, E. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801105105 · Cited by 253
Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04430 · Cited by 251
Alfarouk, K. O., Verduzco, D., Rauch, C., Muddathir, A. K., Bashir, A. H. H., Elhassan, G. O., Ibrahim, M. E., Orozco, J. D. P., Cardone, R. A., Reshkin, S. J., et al. (2014) · Oncoscience · doi:10.18632/oncoscience.109 · Cited by 245
Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G., & Powis, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.233.3.3 · Cited by 240
Forsberg, K., Valyi-Nagy, I., Heldin, C. H., Herlyn, M., & Westermark, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.393 · Cited by 238
Bell, E. L., Klimova, T. A., Eisenbart, J., Schumacker, P. T., & Chandel, N. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02265-06 · Cited by 237
Chan, Y. C., Khanna, S., Roy, S., & Sen, C. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158790 · Cited by 237
Chiavarina, B., Whitaker-Menezes, D., Migneco, G., Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Tanowitz, H. B., Casimiro, M. C., Wang, C., Pestell, R. G., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12908 · Cited by 222
Schwab, L. P., Peacock, D. L., Majumdar, D., Ingels, J. F., Jensen, L. C., Smith, K. D., Cushing, R. C., & Seagroves, T. N. (2012) · Breast Cancer Research · doi:10.1186/bcr3087 · Cited by 220
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer
Vanharanta, S., Shu, W., Brenet, F., Hakimi, A. A., Heguy, A., Viale, A., Reuter, V. E., Hsieh, J. J.-D., Scandura, J. M., & Massagué, J. (2013) · Nature Medicine · doi:10.1038/nm.3029 · Cited by 215
Hypoxia-inducible factors and their roles in energy metabolism
Goda, N., & Kanai, M. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1069-y · Cited by 207
Locasale, J. W., & Cantley, L. C. (2010) · BMC Biology · doi:10.1186/1741-7007-8-88 · Cited by 198
Metabolism and proliferation share common regulatory pathways in cancer cells
Fritz, V, & Fajas, L. (2010) · Oncogene · doi:10.1038/onc.2010.182 · Cited by 192
Shibuya, K., Okada, M., Suzuki, S., Seino, M., Seino, S., Takeda, H., & Kitanaka, C. (2015) · Oncotarget · doi:10.18632/oncotarget.2892 · Cited by 188
Extravasation of polymeric nanomedicines across tumor vasculature
Danquah, M. K., Zhang, X. A., & Mahato, R. I. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.005 · Cited by 188
Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0612 · Cited by 181
Loss of the Mitochondrial Bioenergetic Capacity Underlies the Glucose Avidity of Carcinomas
López-Ríos, F., Sánchez-Aragó, M., García-García, E., Ortega, A. D., Berrendero, J. R., Pozo-Rodríguez, F., López-Encuentra, A., Ballestín, C., & Cuezva, J. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1678 · Cited by 180
Patten, D. A., Lafleur, V. N., Robitaille, G. A., Chan, D. A., Giaccia, A. J., & Richard, D. E. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-01-0025 · Cited by 171
Yang, S., Wu, C., XIONG, Z.-F., & Fang, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3689 · Cited by 169
Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications
Lau, E. Y.-T., Ho, N. P.-Y., & Lee, T. K.-W. (2017) · Stem Cells International · doi:10.1155/2017/3714190 · Cited by 167
Hypoxia-regulated microRNAs in human cancer
Shen, G., Li, X., Jia, Y.-F., Piazza, G. A., & Xi, Y. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.195 · Cited by 164
The VHL-dependent regulation of microRNAs in renal cancer
Neal, C. S., Michael, M. Z., Rawlings, L. H., Van der Hoek, M. B., & Gleadle, J. M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-64 · Cited by 164
Epigenetics: The epicenter of the hypoxic response
Watson, J. A., Watson, C. J., McCann, A., & Baugh, J. (2010) · Epigenetics · doi:10.4161/epi.5.4.11684 · Cited by 162
Epigenetic Regulation by Histone Demethylases in Hypoxia
Hancock, R. L., Dunne, K., Walport, L. J., Flashman, E., & Kawamura, A. (2015) · Epigenomics · doi:10.2217/epi.15.24 · Cited by 161
Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche
Kubota, Y., Takubo, K., & Suda, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.086 · Cited by 160
Comito, G., Calvani, M., Giannoni, E., Bianchini, F., Calorini, L., Torre, E., Migliore, C., Giordano, S., & Chiarugi, P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.042 · Cited by 159
HIF‐1α and HIF‐2α have divergent roles in colon cancer
Imamura, T., Kikuchi, H., Herraiz, M., Park, D., Mizukami, Y., Mino‐Kenduson, M., Lynch, M. P., Rueda, B. R., Benita, Y., Xavier, R. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24032 · Cited by 158
Genetic insights into OXPHOS defect and its role in cancer
Chandra, D., & Singh, K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.023 · Cited by 156
Li, Q. F., Wang, X. R., Yang, Y. W., & Lin, H. (2006) · Cell Research · doi:10.1038/sj.cr.7310072 · Cited by 153
Bayer, C., & Vaupel, P. W. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0085-4 · Cited by 141
Schöning, J., Monteiro, M. J., & Gu, W. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12693 · Cited by 120
Hypoxia: Adapting to High Altitude by Mutating EPAS-1 , the Gene Encoding HIF-2α
Tissot van Patot, M. C., & Gassmann, M. (2011) · High Altitude Medicine & Biology · doi:10.1089/ham.2010.1099 · Cited by 119
Selective Small Molecule Probes for the Hypoxia Inducible Factor (HIF) Prolyl Hydroxylases
Chowdhury, R., Lena, J. I. C., Chan, M. C., Greenald, D., Yeoh, K. K., Tian, Y., McDonough, M. A., Tumber, A., Rose, N. R., Conejo‐García, A., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400088q · Cited by 116
Epigenetics and cancer metabolism
Johnson, C., Warmoes, M. O., Shen, X., & Locasale, J. W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.043 · Cited by 113
Graziano, F., Ruzzo, A., Giacomini, E., et al. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.13 · Cited by 112
Impaired OXPHOS Complex III in Breast Cancer
Owens, K. M., Kulawiec, M., Desouki, M., Vanniarajan, A., & Singh, K. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023846 · Cited by 109
Ježek, P., & Plecitá‐Hlavatá, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.014 · Cited by 106
Zhou, J., Wu, S., Sun, J., Li, F.-Y., Lin, H.-X., Chen, Q., & He, Z. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2246-9 · Cited by 102
Karuppagounder, S. S., & Ratan, R. R. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.28 · Cited by 98
Loayza‐Puch, F., Yoshida, Y., Matsuzaki, T., Takahashi, C., Kitayama, H., & Noda, M. (2010) · Oncogene · doi:10.1038/onc.2010.23 · Cited by 97
Calvani, M., Comito, G., Giannoni, E., & Chiarugi, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038388 · Cited by 94
Mitochondrial Regulation of Oxygen Sensing
Chandel, N. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-500-2_22 · Cited by 94
The expression and significance of HIF-1α and GLUT-3 in glioma
Liu, Y., Li, Y., Tian, R., Liu, W., Fei, Z., Long, Q., Wang, X.-A., & Zhang, X. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.083 · Cited by 79
Seo, B. R., DelNero, P. F., & Fischbach, C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.011 · Cited by 78
Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting.
Ganapathy‐Kanniappan, S., Kunjithapatham, R., & Geschwind, J.-F. H. (2013) · PubMed · Cited by 76
Invited review: decoding the microRNA response to hypoxia
Pocock, R. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0910-5 · Cited by 73
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
Pollard, P. J., Yang, M. H., Su, H., Soga, T., & Kranc, K. R. (2014) · Hypoxia · doi:10.2147/hp.s47968 · Cited by 73
Expression of Glucose Transporter-1 in Cervical Cancer and Its Precursors
Méndez, L., Manci, N., Cantuaria, G. H., Gómez-Marín, O., Peñalver, M., Braunschweiger, P. G., & Nadji, M. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6745 · Cited by 67
Hypoxic pathobiology of breast cancer metastasis
Schito, L., & Rey, S. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.004 · Cited by 66
miRNAs regulate stem cell self-renewal and differentiation
Yu, Z., Li, Y., Fan, H., Liu, Z., & Pestell, R. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00191 · Cited by 63
The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
Hatzimichael, E. C., Dasoula, A., Shah, R., Syed, N., Papoudou‐Bai, A., Coley, H. M., Dranitsaris, G., Bourantas, K. L., Stebbing, J., & Crook, T. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01344.x · Cited by 53
Hypoxia and oxidative stress in breast cancer Tumour hypoxia – therapeutic considerations
Williams, K. J., Cowen, R. L., & Stratford, I. J. (2001) · Breast Cancer Research · doi:10.1186/bcr316 · Cited by 53
Zeng, H., Zhong, Q., Qin, Y., Bu, Q., Han, X., Jia, H.-T., & Liu, H. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-32 · Cited by 52
Lee, H., Lee, T., Lee, N., Yang, E. G., Lee, C., Lee, J., Moon, E., Ha, J., & Park, H. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr034 · Cited by 50
Chen, X., Lü, P., Zhou, S., Zhang, L., Zhao, J., & Tang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14570 · Cited by 49
Pathways for Oxygen Regulation and Homeostasis
Kaelin, W. G., Ratcliffe, P. J., & Semenza, G. L. (2016) · JAMA · doi:10.1001/jama.2016.12386 · Cited by 43
Defining the Molecular Basis of Tumor Metabolism: a Continuing Challenge Since Warburg’s Discovery
de Souza, A. C. S., Justo, G. Z., de Araújo, D. R., & Cavagis, A. D. M. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335792 · Cited by 39
Impact of hypoxia inducible factors on estrogen receptor expression in breast cancer cells
Wolff, M., Kosyna, F. K., Dunst, J., JELKMANN, W. E. B., & Depping, R. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.11.002 · Cited by 37
Hatzimichael, E. C., Dranitsaris, G., Dasoula, A., Benetatos, L., Stebbing, J., Crook, T., & Bourantas, K. L. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.n.047 · Cited by 36
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
Yang, M., Su, H., Soga, T., Kranc, K. R., & Pollard, P. J. (2014) · Dove Medical Press (Taylor and Francis Group) · Cited by 29
Kotake‐Nara, E., & Saida, K. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.026 · Cited by 27
Identification of prolyl hydroxylation modifications in mammalian cell proteins
Arsenault, P. R., Heaton-Johnson, K. J., Li, L.-S., Song, D., Ferreira, V. S., Patel, N., Master, S. R., & Lee, F. S. (2014) · PROTEOMICS · doi:10.1002/pmic.201400398 · Cited by 25
The tumour microenvironment links complement system dysregulation and hypoxic signalling
Olcina, M. M., Kim, R. K., Melemenidis, S., Graves, E. E., & Giaccia, A. J. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180069 · Cited by 22
Deppe, J., Popp, T., Egea, V., Steinritz, D., Schmidt, A., Thiermann, H., Weber, C., & Ries, C. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1549-y · Cited by 20
Bhatia, M., Therese, C., Di, G., & Tonissen, K. F. (2013) · InTech eBooks · doi:10.5772/55185 · Cited by 20
Differential effect of hypoxia and acidity on lung cancer cell and fibroblast metabolism
Giatromanolaki, A. N., Liousia, M., Arelaki, S., Kalamida, D., Pouliliou, S., Mitrakas, A. G., Tsolou, A., Sivridis, E., & Koukourakis, M. I. (2017) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0197 · Cited by 16
Pluripotent and Multipotent Stem Cells Display Distinct Hypoxic miRNA Expression Profiles
Agrawal, R., Dale, T. P., Al-Zubaidi, M. A., Malgulwar, P. B., Forsyth, N. R., & Kulshreshtha, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164976 · Cited by 12
Self-citation
Cited by
Revisiting the Warburg effect: historical dogma versus current understanding
Vaupel, P., & Multhoff, G. (2021) · The Journal of Physiology · doi:10.1113/jp278810 · Cited by 830
Emami Nejad, A., Najafgholian, S., Rostami, A., Sistani, A., Shojaeifar, S., Esparvarinha, M., Nedaeinia, R., Haghjooy Javanmard, S., Taherian, M., Ahmadlou, M., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-020-01719-5 · Cited by 693
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., You, L., Nepovimova, E., Heger, Z., Wu, W., Kuca, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 485
Application of Radiosensitizers in Cancer Radiotherapy
Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s290438 · Cited by 479
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Tirpe, A. A., Gulei, D., Ciortea, S. M., Crivii, C., & Berindan-Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246140 · Cited by 438
Metadata
- Authors
- Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2019-01-29
- Volume
- 7
- Pages
- 4-4
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W2914525558
- Cited by
- 503
- References
- 159
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.